Bioavailability and Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets in Healthy Volunteers: Results from Three Randomized, Crossover, Open-Label, Phase 1 Studies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6536
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Bioavailability and Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets in Healthy Volunteers: Results from Three Randomized, Crossover, Open-Label, Phase 1 Studies ; volume:8 ; number:2 ; day:1 ; month:8 ; year:2019 ; pages:449-460 ; date:12.2019
Neurology and Therapy ; 8, Heft 2 (1.8.2019), 449-460, 12.2019
- Classification
-
Medizin, Gesundheit
- Creator
-
deVries, Tina
Dentiste, Angela
Handiwala, Lata
Jacobs, David
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40120-019-0144-1
- URN
-
urn:nbn:de:101:1-2020070114054648995806
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- deVries, Tina
- Dentiste, Angela
- Handiwala, Lata
- Jacobs, David
- SpringerLink (Online service)
Other Objects (12)
Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets
A prospective cohort conversion study of twice-daily to once-daily extended-release tacrolimus: role of ethnicity
Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers
Real-World Study of Once-Daily, Extended-Release Tacrolimus Versus Twice-Daily, Immediate-Release Tacrolimus in Kidney Transplantation: Clinical Outcomes and Healthcare Resource Utilization
O413 Pharmacokinetics (PK) of once-daily etravirine (ETR) without and with once-daily darunavir/ritonavir (DRV/r) in antiretroviral-naïve HIV-1 infected adults
Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation
Bioavailability of intravenous fosphenytoin sodium in healthy Japanese volunteers
Use of once-daily raltegravir-based HAART in HIV-infected injection drug users
The use of a darunavir/ritonavir once-daily regimen in two pregnant women
Population pharmacokinetic modelling of once-daily ritonavir-boosted darunavir in HIV-infected patients
Once-daily regimens were associated with a higher rate of self-chosen discontinuations
Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets
A prospective cohort conversion study of twice-daily to once-daily extended-release tacrolimus: role of ethnicity
Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers
Real-World Study of Once-Daily, Extended-Release Tacrolimus Versus Twice-Daily, Immediate-Release Tacrolimus in Kidney Transplantation: Clinical Outcomes and Healthcare Resource Utilization
O413 Pharmacokinetics (PK) of once-daily etravirine (ETR) without and with once-daily darunavir/ritonavir (DRV/r) in antiretroviral-naïve HIV-1 infected adults
Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation
Bioavailability of intravenous fosphenytoin sodium in healthy Japanese volunteers
Use of once-daily raltegravir-based HAART in HIV-infected injection drug users
The use of a darunavir/ritonavir once-daily regimen in two pregnant women
Population pharmacokinetic modelling of once-daily ritonavir-boosted darunavir in HIV-infected patients
Once-daily regimens were associated with a higher rate of self-chosen discontinuations
Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets
A prospective cohort conversion study of twice-daily to once-daily extended-release tacrolimus: role of ethnicity
Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers
Real-World Study of Once-Daily, Extended-Release Tacrolimus Versus Twice-Daily, Immediate-Release Tacrolimus in Kidney Transplantation: Clinical Outcomes and Healthcare Resource Utilization
O413 Pharmacokinetics (PK) of once-daily etravirine (ETR) without and with once-daily darunavir/ritonavir (DRV/r) in antiretroviral-naïve HIV-1 infected adults
Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation
Bioavailability of intravenous fosphenytoin sodium in healthy Japanese volunteers
Use of once-daily raltegravir-based HAART in HIV-infected injection drug users
The use of a darunavir/ritonavir once-daily regimen in two pregnant women
Population pharmacokinetic modelling of once-daily ritonavir-boosted darunavir in HIV-infected patients